![These highlights do not include all the information needed to use OXAPROZIN TABLETS safely and effectively. See full prescribing information for OXAPROZIN TABLETS. OXAPROZIN tablets, for oral useInitial U.S. Approval: 1992 These highlights do not include all the information needed to use OXAPROZIN TABLETS safely and effectively. See full prescribing information for OXAPROZIN TABLETS. OXAPROZIN tablets, for oral useInitial U.S. Approval: 1992](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=Image-02.jpg&id=668036)
These highlights do not include all the information needed to use OXAPROZIN TABLETS safely and effectively. See full prescribing information for OXAPROZIN TABLETS. OXAPROZIN tablets, for oral useInitial U.S. Approval: 1992
![DE69733752T2 - DRUGS CONTAINING OXAPROCINE SODIUM SALT, CALIUM SALT, OR TRIS (HYDROXYMETHYL) AMINOMETHANE SALT - Google Patents DE69733752T2 - DRUGS CONTAINING OXAPROCINE SODIUM SALT, CALIUM SALT, OR TRIS (HYDROXYMETHYL) AMINOMETHANE SALT - Google Patents](https://patentimages.storage.googleapis.com/59/57/e1/94fd9ad0b6a772/00010001.png)
DE69733752T2 - DRUGS CONTAINING OXAPROCINE SODIUM SALT, CALIUM SALT, OR TRIS (HYDROXYMETHYL) AMINOMETHANE SALT - Google Patents
![Nonsteroidal Anti-inflammatory Agent Oxaprozin 600 mg Film Coated Tablet Bottle 500 Tablets - Suprememed Nonsteroidal Anti-inflammatory Agent Oxaprozin 600 mg Film Coated Tablet Bottle 500 Tablets - Suprememed](https://www.suprememed.com/wp-content/uploads/2022/02/nonsteroidalantiinflammatoryagentoxatev00093092405-595x595.jpg)